At the Niigata University Hospital, various kinds of prosthetic valves such as the Starr-Edwards noncloth-and cloth-covered, Bjork-Shiley tilting disc, and Carpentier-Edwards porcine valves, have been used from September, 1965 to March, 1979 for replacement of diseased valves on 176 patients.
replace a mitral valve in 1965 for the first time. Since then to March, 1979 , 337 patients with acquired valvular heart disease have been operated on.
In this paper, our 13 year-experience with isolated mitral valve replacement is presented and the problems concerning postoperative long-term results are discussed.
MATERIALS AND METHODS
Numbers of overall prosthetic valve replacements are shown in Table I . Among these, 176 patients underwent prosthetic mitral valve replacement between September, 1965 and March, 1979. Hospital death was 5.7% and late death 13%.
In Table II , materials of this paper are summarized. There were 73 men and 103 women. Rheumatic valvular disease was the most common causative factor, and it was found in 159 patients. Mitral regurgitation due to myxomatous degeneration or ruptured chorda tendinea was noted in 17 patients. Only one patient was associated with ischemic heart disease. Preoperative NYHA functional class revealed 25 patients in class II, 138 in class III, and 13 in class IV.
Of the 176 valves replaced, 51 were Starr-Edwards noncloth-covered; 82, StarrEdwards cloth-covered; 21, Bjork-Shiley; 20, Carpentier-Edwards porcine valves, and 2, other valves.
In these patients, actuarial and an event-free curves for survivors were constructed and analyzed according to the methods of Cutler and Ederer.
RESULTS
In Fig. 1 , actuarial survival curves for various prosthetic valves were compared. At 5 years, the patients with Starr-Edwards noncloth-and clothcovered valves exhibited a survival rate of 90 and 84% respectively. The 8-year survival rates were 87 and 81%.
Those with Carpentier-Edwards porcine and Bjork-Shiley tilting disc valves showed a survival rate of 93% at 1 and 3 years, respectively.
The mean ages of those patients were shown on the lower part of the fi gure. A gradual increase in age was evident in the patients with newly developed prosthesis. In this connection, the mean age of the patients operated in the 3 time frame was compared in Fig. 2 . The patients were divided into the first, second, and third group depending on the time of operation; the patients of the first group were operated more than 10 years ago. Those in the second and third group were operated between 5 and 10 years ago and in recent 5 The mean age of the 3 groups was 27.7, 35.5, and 40 years. There was a significant difference between them.
Moreover, the patients were divided into those more and those less than 50 years of age at operation and the survival rates were shown in Fig. 3 . At 6 years of follow-up, the survival rate of those less than 50 years was 86%, but for those more than 50 years, it was 72%.
The actuarial curve illustrating the time-related incidence of thromboembolism in all patients with mitral valve prosthesis was shown in Fig. 4 . Thromboembolism included major and minor episodes of neurologic deficits.
Major thromboembolism consisting of cerebral embolus associated with residual neurologic deficits developed at the rates of 10 and 12% at 5 and 10 years respectively. Incidences of minor episodes with transient ischemic attack were 13 and 20%. In terms of per year until 8 year-follow-up, the overall embolic rate was 4%.
Since 1973, as a policy of anticoagulation, for the patients who were unable to be maintained in a suitable therapeutic range with warfarin, bucolome was combined with it. In Fig. 5 , the embolic incidence of 81 survivors who had surgery before 1973 was compared with that of 85 survivors who had been operated on since 1973. At 6 years, the probability of being free of major thromboembolism was 85% in the former and 96% in the latter group. As to minor embolic episode, it was 80% for the former and 96% for the latter group.
The effects of the new policy of anticoagulation on the patients with Starr-Edwards cloth-covered valve were shown in Fig. 6 . The 6-year major thromboembolism-free rate is 92% in the patients operated before 1973 and 96% for those operated since 1973. The rates for minor episode are 85 and 100% in those groups, respectively. Reoperation due to valve failure including valvular regugitation, thromboembolic valvular occlusion and multiple embolic episodes was studied.
The actuarial reoperation rate at 7 years was 7% for the patients with Starr-Edwards noncloth-covered and 1% for those with cloth-covered valve. Within the constraint of the short follow-up time, no reoperation was necessary in the patients who received Bjork-Shiley tilting disc and CarpentierEdwards porcine valves.
Overall mortality and morbidity actuarial survival curve for each of the valve types were shown in Fig. 8 . Each curve represents the percentage of patients free of death or any previously mentioned complications as a function of time.
Finally, concerning selection of a particular valve for a patient, one One major thromboenbolic episode in the remaining 8 patients without warfarin.
problem which we have been unable to manage was warfarin administration in pregnant women. Table III shows the teratogenic effect of warfarin on 11 newborn infants.
In 4, neonatal death due to complicated anomalies, polidactilic left hand, microphthalmus of the right eye and maldevelopment of nasal cartilage were found.
DISCUSSION
Regarding the survival rate of the patients with Starr-Edwards nonclothand cloth-covered ball valves, that for all operative survivors was 83% at 6 years and 81% at 10 years. Survival rates for patients with noncloth-and cloth-covered valves are 87 and 81% at 6 years respectively.
The overall survival rate shown by Macmanus et al1) and Starr et al2) was 76% at 6 years and 58% at 10 years. For those with noncloth-and cloth-covered valves, the rate was 78 and 72% at 6 years. At 12 years, the survival rate for the former was 50%.
To discuss data of the same prostheses in different countries, it is necessary to consider preoperative factors which have proven to be significant in correlation to later postoperative survival.
These include age,3),5) NYHA functional class,4),5) LVEDP,4),5) cardiac index,4),5) associated coronary artery disease,4)-6) and ischemic mitral dysfunction as primary etiology.5), 6) Hammermeister et al3) demonstrated that only age was significantly predictive of survival in surgically treated mitral valve disease patients and the difference was evident at the age of 60. Solomon et al5) also pointed out that the patient age of over 60 years had a deleterious effect on 5-year survival.
The mean age of our patients with Starr-Edwards noncloth-and clothcovered valves were 30.2 and 36.4 years, respectively and so the patients aged over 60 years at operation were very few. This may be one of the causes which have been contributed to a more favorable long-term survival than in the western countries.
Concomitantly, the incidence of ischemic mitral dysfunction and associated coronary artery disease was also very low as indicated in Table II. For operative survivors, valve replacement adds a new set of modifications which affect outcome and which are not related to preoperative status such as emboli, bleeding, valve dysfunction and valve infection.
In these, the problem of thromboembolism continues to be significant, Except for the report of Winter et al9) with a high incidence of short term follow-up, it can be pointed out that applying a cloth covering to the housing of caged ball valve appears to lower the incidence of thromboembolism.
It is also important to consider the effect of controlling anticoagulant therapy on thromboembolism.
In Fig. 5 , the patients with model 6300 series valve who had been operated on since 1973 and were unable to be Vol.21 No. 5 
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maintained under a suitable therapeutic range with warfarin, were given doses with bucolome combined.12) The probability of being free of major and minor thromboembolism at 6 years were 92 and 85% in the patients operated before 1973, and 96 and 100% in those operated since 1973. No major thromboembolism has been found in our patients with Bjork-Shiley tiliting or Carpentier-Edwards porcine valves. Accordingly, the conclusion of Gott et al13) on this subject differs a little from our experience in which the thromboembolic rate can be decreased with the advance of time even in the patients with a ball or disc prosthesis.
The actuarial reoperation rate was 13% at 6 years6) and 12% at 12 years for the Starr-Edwards model 6120 prosthesis.1) That of the model 6300 series valve was 9% at 6 years.14) In our patients, the rate was 7% and 1% at 8 years for the model 6120 and 6300 series valve respectively. Reoperation had been carried out mostly in the patients with valvular regurgitation, thrombotic valvular occlusion, multiple embolic episodes, infective endocarditis and hemodynamic valvular dysfunction. Macmanus et al1) reported that they had not encountered any structural failure with the model 6120 valve in either the mitral or aortic position. This seems to be true in our experience, also.
Finally, as mentioned previously, prosthetic valve implantation is subject to risks of several types and it is useful to know the combined prognosis related to the simultaneous occurrence of these events. Cumulative eventfree or composite morbidity and mortality actuarial curve of our patients with Starr-Edwards model 6120 and 6300 series valves at 6 and 10 years was a little better than those reported by Starr et al2) and Stinson.6) Also, the incidence of the most common cerebrovascular accident following valve replacement decreased with time and subsequently, the patients with the recently available valves in Japan have been almost free of this complication in our hospital. In summary, mitral valve replacement involves many factors related both to the patients characteristics and the type of valve substitute utilized. Our long-term follow-up results with Starr-Edwards ball valves was good even when taking into account age at operation. Although our experience on xenograft valves has been with the restriction of a short follow-up period, the data collected through the ball valves present basic concepts for selection of ball valves, tilting disc valves or the porcine aortic xenograft.
